Clinical and Experimental Dermatology

Cover image for Clinical and Experimental Dermatology

September 1992

Volume 17, Issue Supplement s1

Pages 1–70

    1. Introduction (page 1)

      R.J. HAY, Y.M. CLAYTON, A. del PALACIO and A.M. POLAK

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00267.x

    2. Treatment of dermatomycoses and onychomycoses—state of the art (pages 2–5)

      R.J. HAY

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00268.x

    3. Clinical manifestations of onychomycosis (pages 6–7)

      N. ZAIAS

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00269.x

    4. Preclinical data and mode of action of amorolfine (pages 8–12)

      A.M. POLAK

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00270.x

    5. Morphological changes associated with growth inhibition of Trichophyton mentagrophytes by amorolfine (pages 13–17)

      Y. NISHIYAMA, Y. ASAGI, T. HIRATANI, H. YAMAGUCHI, N. YAMADA and M. OSUMI

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00271.x

    6. Influence of amorolfine on the morphology of Candida albicans and Trichophyton mentagrophytes (pages 18–25)

      J. MÜLLER, A. POLAK-WYSS and W. MELCHINGER

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00272.x

    7. Loceryl® nail lacquer—realization of a new galenical approach to onychomycosis therapy (pages 26–28)

      F. PITTROF, J. GERHARDS, W. ERNI and G. KLECAK

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00273.x

    8. Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation (pages 33–36)

      G. RONCARI, CH. PONELEE, R. ZUMBRUNNEN, A. GUENZI, J. DINGEMANSE and J.H.G. JONKMAN

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00275.x

    9. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses (pages 37–40)

      Y.M. CLAYTON

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00276.x

    10. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly (pages 41–43)

      J. LAUHARANTA

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00277.x

    11. Dose-finding study of amorolfine cream (0·125%, 0·25% and 0·5%) in the treatment of dermatomycoses (pages 50–55)

      A. del PALACIO, L. GIP, M. BERGSTRAESSER and M. ZAUG

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00279.x

    12. Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses (pages 56–60)

      S. NOLTING, G. SEMIG, H. K. FRIEDRICH, M. DIETZ, R. RECKERS-CZASCHKA, M. BERGSTRAESSER and M. ZAUG

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00280.x

    13. Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview) (pages 61–70)

      M. ZAUG and M. BERGSTRAESSER

      Article first published online: 27 APR 2006 | DOI: 10.1111/j.1365-2230.1992.tb00281.x

SEARCH

SEARCH BY CITATION